SCHEMBL14975444

SCHEMBL14975444

O=C(O)n1cccc(CCCCCCCc2ccccc2)c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BID P55957 1/20 0.50
▸ BCL2L1 Q07817 1/20 0.50
▸ MCL1 Q07820 1/20 0.50
▸ BAK1 Q16611 1/20 0.50
▸ MAPT P10636 1/20 0.49
▸ RXFP1 Q9HBX9 1/20 0.49
▸ NAMPT P43490 1/20 0.45
▸ HDAC1 Q13547 3/20 0.44
▸ HDAC2 Q92769 2/20 0.44
▸ GSK3A P49840 1/20 0.44
▸ GSK3B P49841 1/20 0.44
▸ ALOX5 P09917 1/20 0.44
▸ CYSLTR2 Q9NS75 1/20 0.44
▸ CYSLTR1 Q9Y271 1/20 0.44
▸ HDAC3 O15379 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ ADRA1A P35348 1/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ SLC6A3 Q01959 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14975362 1.00 BID (0.50) BIDBCL2L1MCL1BAK1MAPT
SCHEMBL16058352 1.00 BID (0.50) BIDBCL2L1MCL1BAK1MAPT
SCHEMBL14975000 1.00 BID (0.50) BIDBCL2L1MCL1BAK1MAPT
SCHEMBL16056739 0.97 BID (0.47) BIDBCL2L1MCL1BAK1MAPT
SCHEMBL14975640 0.90 NR1H2 (0.44) BIDBCL2L1MCL1BAK1MAPT
SCHEMBL14975345 0.88 SLC6A5 (0.41) BIDBCL2L1MCL1BAK1MAPT
SCHEMBL16056989 0.88 HDAC3 (0.42) BIDBCL2L1MCL1BAK1MAPT
SCHEMBL16057333 0.85 LTB4R (0.47) HDAC1HDAC2ALOX5HDAC3HDAC4
SCHEMBL16058818 0.85 HDAC1 (0.46) HDAC1CYSLTR2CYSLTR1SMN1; SMN2HDAC8
SCHEMBL16057559 0.85 TBXAS1 (0.57) HDAC1HDAC2HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2782567-B1 DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) UNIV CALIFORNIA (US) 2017-03-22 — — EP disclosed
US-20160235707-A1 DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) FOND ST ITALIANO TECNOLOGIA (IT) 2016-08-18 — — US disclosed
US-9353075-B2 Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-05-31 — — US disclosed
EP-2782567-A1 DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) The Regents of The University of California (US) 2014-10-01 — — EP disclosed
US-20130281490-A1 Disubstituted Beta-lactones as Inhibitors of N-Acylethanolamine Acid Amidase (NAAA) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2013-10-24 — — US disclosed
WO-2013078430-A1 DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-05-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281490-A1 Disubstituted Beta-lactones as Inhibitors of N-Acylethanolamine Acid Amidase (NAAA) NAAA, FAAH, FAAH2 BID 1018/4885BCL2L1 3486/4885MCL1 3490/4885
US-20160235707-A1 DISUBSTITUTED BETA-LACTONES AS INHIBITORS OF N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) NAAA, FAAH, FAAH2 BID 1018/4885BCL2L1 3486/4885MCL1 3490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback